359 related articles for article (PubMed ID: 37437351)
1. An overview of anti-SARS-CoV-2 and anti-inflammatory potential of baicalein and its metabolite baicalin: Insights into molecular mechanisms.
Dinda B; Dinda M; Dinda S; De UC
Eur J Med Chem; 2023 Oct; 258():115629. PubMed ID: 37437351
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory Efficacy of Main Components of
Lin CH; Chang HJ; Lin MW; Yang XR; Lee CH; Lin CS
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474182
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
4.
Liu H; Ye F; Sun Q; Liang H; Li C; Li S; Lu R; Huang B; Tan W; Lai L
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):497-503. PubMed ID: 33491508
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Review of Natural Flavonoids with Anti-SARS-CoV-2 Activity.
Yang JY; Ma YX; Liu Y; Peng XJ; Chen XZ
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985705
[TBL] [Abstract][Full Text] [Related]
6. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients.
Su HX; Yao S; Zhao WF; Li MJ; Liu J; Shang WJ; Xie H; Ke CQ; Hu HC; Gao MN; Yu KQ; Liu H; Shen JS; Tang W; Zhang LK; Xiao GF; Ni L; Wang DW; Zuo JP; Jiang HL; Bai F; Wu Y; Ye Y; Xu YC
Acta Pharmacol Sin; 2020 Sep; 41(9):1167-1177. PubMed ID: 32737471
[TBL] [Abstract][Full Text] [Related]
7. Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments.
Abdurrahman L; Fang X; Zhang Y
Curr Mol Med; 2022; 22(7):621-639. PubMed ID: 34645374
[TBL] [Abstract][Full Text] [Related]
8. Roles of flavonoids against coronavirus infection.
Russo M; Moccia S; Spagnuolo C; Tedesco I; Russo GL
Chem Biol Interact; 2020 Sep; 328():109211. PubMed ID: 32735799
[TBL] [Abstract][Full Text] [Related]
9. Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase.
Zandi K; Musall K; Oo A; Cao D; Liang B; Hassandarvish P; Lan S; Slack RL; Kirby KA; Bassit L; Amblard F; Kim B; AbuBakar S; Sarafianos SG; Schinazi RF
Microorganisms; 2021 Apr; 9(5):. PubMed ID: 33921971
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
11. Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review.
Kaul R; Paul P; Kumar S; Büsselberg D; Dwivedi VD; Chaari A
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681727
[TBL] [Abstract][Full Text] [Related]
12. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
Khare P; Sahu U; Pandey SC; Samant M
Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
[TBL] [Abstract][Full Text] [Related]
13. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
Rohilla S
Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
[TBL] [Abstract][Full Text] [Related]
14. Chrysin 7-O-β-D-glucuronide, a dual inhibitor of SARS-CoV-2 3CL
Yi Y; Yu R; Xue H; Jin Z; Zhang M; Bao YO; Wang Z; Wei H; Qiao X; Yang H
Int J Antimicrob Agents; 2024 Jan; 63(1):107039. PubMed ID: 37981073
[TBL] [Abstract][Full Text] [Related]
15. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
16. Potential inhibitors of SARS-CoV-2: recent advances.
Jamalipour Soufi G; Iravani S
J Drug Target; 2021 Apr; 29(4):349-364. PubMed ID: 33210953
[TBL] [Abstract][Full Text] [Related]
17. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
[TBL] [Abstract][Full Text] [Related]
18. A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases.
Li Z; Wu J; Zhou J; Yuan B; Chen J; Wu W; Mo L; Qu Z; Zhou F; Dong Y; Huang K; Liu Z; Wang T; Symmes D; Gu J; Sho E; Zhang J; Chen R; Xu Y
mBio; 2021 Oct; 12(5):e0254221. PubMed ID: 34634931
[TBL] [Abstract][Full Text] [Related]
19. The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion.
Chen TH; Tsai MJ; Chang CS; Xu L; Fu YS; Weng CF
J Infect Public Health; 2023 Jan; 16(1):42-54. PubMed ID: 36470006
[TBL] [Abstract][Full Text] [Related]
20. Both Baicalein and Gallocatechin Gallate Effectively Inhibit SARS-CoV-2 Replication by Targeting M
Xiao T; Cui M; Zheng C; Zhang P; Ren S; Bao J; Gao D; Sun R; Wang M; Lin J; Zhang L; Li M; Li D; Zhou H; Yang C
Inflammation; 2022 Jun; 45(3):1076-1088. PubMed ID: 34822072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
